RBC Europe’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-166
| Closed | -$797 | – | 1243 |
|
2020
Q4 | $797 | Hold |
166
| – | – | ﹤0.01% | 1097 |
|
2020
Q3 | $666 | Hold |
166
| – | – | ﹤0.01% | 1042 |
|
2020
Q2 | $762 | Hold |
166
| – | – | ﹤0.01% | 1002 |
|
2020
Q1 | $541 | Hold |
166
| – | – | ﹤0.01% | 983 |
|
2019
Q4 | $715 | Hold |
166
| – | – | ﹤0.01% | 1002 |
|
2019
Q3 | $653 | Sell |
166
-604
| -78% | -$2.38K | ﹤0.01% | 1001 |
|
2019
Q2 | $3.58K | Hold |
770
| – | – | ﹤0.01% | 947 |
|
2019
Q1 | $3.23K | Hold |
770
| – | – | ﹤0.01% | 965 |
|
2018
Q4 | $2.64K | Hold |
770
| – | – | ﹤0.01% | 977 |
|
2018
Q3 | $3.3K | Hold |
770
| – | – | ﹤0.01% | 1004 |
|
2018
Q2 | $2.86K | Hold |
770
| – | – | ﹤0.01% | 1035 |
|
2018
Q1 | $3.23K | Hold |
770
| – | – | ﹤0.01% | 1015 |
|
2017
Q4 | $4.53K | Buy |
770
+604
| +364% | +$3.55K | ﹤0.01% | 969 |
|
2017
Q3 | $714 | Buy |
+166
| New | +$714 | ﹤0.01% | 1090 |
|